-
Baicalein: A 12-LOX Lens for Translation
2026-08-25
Baicalein is more than a flavonoid compound for cancer research: it is a pathway-focused tool for connecting 12-LOX biology, arachidonic acid metabolism, apoptosis, inflammation, and treatment selectivity. This article outlines how translational researchers can use Baicalein to build stronger mechanistic and combination-treatment evidence while avoiding premature claims about clinical utility.
-
Itraconazole for Candida Biofilm Research
2026-08-25
Itraconazole is a triazole antifungal agent for connecting Candida biofilm phenotypes with CYP3A4-mediated drug interaction studies. This guide provides a practical workflow for solvent handling, PP2A–autophagy experiments, dose-response design, and troubleshooting biofilm variability.
-
Ranolazine in Cardio-Hepatic Assay Design
2026-08-24
Ranolazine is an anti-ischemic agent with established effects on late sodium current and cellular energy metabolism. This article develops a practical, evidence-graded framework for testing whether metabolic perturbation influences HBV-associated TBK1 signaling and autophagy without overstating an unproven antiviral role.
-
Berberrubine and Gut–Liver Metabolism in NAFLD
2026-08-24
The 2022 Frontiers in Pharmacology study shows that berberrubine, a major berberine metabolite, improves diet-induced hepatic steatosis and insulin resistance while remodeling metabolic protein networks and gut microbiota. Its comparative design with berberine supports berberrubine as a biologically active metabolite, but the findings remain preclinical and do not establish causality between microbial changes and liver improvement.
-
gamma-Glu-Cys Workflows for Glutathione Research
2026-08-23
Use gamma-Glu-Cys as a controlled substrate for glutathione synthetase enzyme assay development, metabolite profiling, and peptide-production studies. Its defined purity, high solubility, and fresh-solution workflow also make it useful for comparing microbial media, plant stress extracts, and thiol-reactive peptide synthesis conditions.
-
Rapamycin (Sirolimus): mTOR Research Guide
2026-08-22
Rapamycin, also called Sirolimus, is an FKBP12-dependent mTOR inhibitor used to study immune activation, growth control, cancer biology, and mitochondrial disease models. Its reported 0.1 nM mTOR IC50 is a benchmark rather than a universal concentration for every assay.
-
Fluconazole Workflows for Resistance Research
2026-08-22
Use Fluconazole as a mechanistic benchmark, susceptibility reference, and comparator in fungal pathogenesis workflows. This guide connects solvent handling, microdilution design, Candida infection models, and resistance-focused troubleshooting to more reproducible experimental decisions.
-
MEHP, AhR, and Ovarian Follicle Toxicity
2026-08-21
This 2024 study shows that mono(2-ethylhexyl) phthalate (MEHP) activates the aryl hydrocarbon receptor (AHR) in mouse ovarian antral follicles, linking receptor signaling to impaired follicle growth and estrogen production. Pharmacological blockade with CH 223191 partially or fully mitigated several endpoints, providing mechanistic support for AHR involvement in phthalate-related ovarian toxicity.
-
7ACC2: A Monocarboxylate Transporter 1 Inhibitor
2026-08-20
7ACC2 combines nanomolar lactate uptake inhibition with interference in mitochondrial pyruvate transport, enabling more informative cancer metabolism research than a single-pathway assay. This guide shows how to connect tumor-cell flux measurements with radiosensitization and tumor-associated macrophage studies while keeping direct evidence separate from testable hypotheses.
-
β-Elemene Assay Reliability: Practical Q&A
2026-08-20
This scenario-based guide explains how β-Elemene (SKU C5505) can be incorporated into cell viability, adipogenesis, cytotoxicity, and mechanism-focused assays. It covers solvent control, dose selection, orthogonal readouts, interpretation limits, and practical supplier-selection criteria supported by product specifications and a recent 3T3-L1 study.
-
3-Hydroxybutyrate (BHBA): From Ketosis to Cell Fate
2026-08-19
3-Hydroxybutyrate (BHBA) is more than a fuel: it connects ketone body signaling, ferroptosis control, membrane biology, and chromatin regulation. This article presents an assay-centered framework for distinguishing these mechanisms and translating ketosis research into reproducible experiments.
-
Exemestane for Reproducible Aromatase Assays
2026-08-19
This scenario-driven guide explains how Exemestane (SKU A1296) can support controlled estrogen biosynthesis inhibition in cell viability, proliferation, and hormone-dependent cancer assays. It connects mechanism, formulation, protocol design, data interpretation, and practical supplier selection to improve experimental clarity.
-
Asunaprevir (BMS-650032) HCV Workflows
2026-08-18
Asunaprevir (BMS-650032) supports mechanism-led studies that connect NS3/4A protease inhibition with HCV RNA replication inhibition across genotype-aware cellular models. This practical guide covers stock preparation, orthogonal readouts, assay controls, troubleshooting, and how a cross-domain screening framework can improve antiviral assay design.
-
Protease Inhibitor Cocktail: Assay Reliability
2026-08-18
A scenario-based guide to using Protease Inhibitor Cocktail (100X in DMSO, EDTA plus), SKU K1019, when viability, proliferation, or cytotoxicity studies require reliable protein readouts. It explains formulation, compatibility, workflow controls, interpretation, and practical vendor-selection criteria.
-
TET2 Metabolite Binding: A Practical STD NMR Protocol
2026-08-17
Zhang, Cheng, and Ye present an integrated workflow that combines biochemical activity assays with saturation transfer difference NMR to distinguish TET2-binding metabolites from compounds that functionally regulate the enzyme. The protocol validates known TET2 activators and inhibitors while providing a practical route for discovering additional metabolic regulators, including glyoxylate.